Associate Professor Adrian Tase

Associate Professor Adrian Tase

Emergency County Hospital Pitesti Arges, Pitesti (Romania)

Member of:

Adrian G. Tase, MD, PhD, BA, FESC, FACC, FAPSC, currently serves as Associate Professor of Internal Medicine and Pharmacology in the University of Pitesti, College of Medicine, as Founder, Head, and Managing Cardiologist in the Coronary Care Unit of the Emergency Hospital Prefecture Arges, Pitesti, and Consulting Cardiologist in MedLife Regional Hospital Piteşti, Romania. He graduated MD in UMPh Craiova (1984), and the Doctorate in Medicine in the UMPh 'Carol Davila' Bucharest (2005) in the field of Cardiovascular Pharmacology (RAAS modulation). Dr. Tase completed cardiology degrees in the Institute of Cardiovascular Disease 'C. C. Iliescu' Bucharest. Adrian Tase also graduated the Professional Diploma in Management at Codecs Open University, UK, as a Bachelor of Arts (2006). He also attended two communication courses in European Training Institute Brussels (2007, 2009). Assoc. Prof. Adrian Tase is a Fellow of the European Society of Cardiology (since 2007), Fellow of the American Coll

Presentations

A medical impact of war: the hypertension crises dynamic in an adjacent population

Event: ESC Congress 2023

Topic: Blood Pressure Measurement

Session: Challenges in hypertension management and gender aspects

Access

Added-on trimetazidine could lower the risk of incidental left ventricular dysfunction +/- heart failure in epirubicinum recipients for bladder cancer

Event: ESC Congress 2017

Topic: Cardiotoxicity of drugs

Session: Chronic heart failure (CHF)

Access

Uninterrupted ivabradine treatment may provide lasting reduction of persistent sinus tachycardia with preserved airways physiology in lung cancer patients: a 48 months retrospective study

Event: ESC Congress 2016

Topic: Drug therapy

Session: Best Posters in anticoagulants in day to day practice - Issues to bear in mind

Access

Associate Professor Adrian Tase

Biography

Contributor content

A medical impact of war: the hypertension crises dynamic in an adjacent population

Added-on trimetazidine could lower the risk of incidental left ventricular dysfunction +/- heart failure in epirubicinum recipients for bladder cancer

Uninterrupted ivabradine treatment may provide lasting reduction of persistent sinus tachycardia with preserved airways physiology in lung cancer patients: a 48 months retrospective study

ESC 365 is supported by